4[3]Joseph P,Lynch IH,Eric W,et al.Corticosteroids in idiopathic pulmonary fibrosis[J].Current Opinion in Pulmonary Medicine,2001,7(5):298-308.
5[5]Iyer SN,Hyde DM,Giri SN.Anti-inflammatory effect of pirfenidone in the bleomycin-hamster model of lung inflammation[J].Inflammation,2000,24(12):477-491.
6[7]Arslan SO,Zerin M,Vural H,et al.The effect of melatonin on bleomycin-induced pulmonary fibrosis in rats[J].J Pineal Res,2002,32(23):21-25.
7[8]Darryl CZ.The lipoxygenase pathway.A New therapeutic target for treatment of pulmonary fibrosis[J].Am J Respir Crit Care Med,2002,165(2):146-147.
8[9]Joseph AL,Luis AO.Antifibrotic therapy for the treatment of pulmonary fibrosis[J].Am J Med Sci,2001,322 (7):213-221.
4[3]Joseph P,Lynch IH,Eric W,et al.Corticosteroids in idiopathic pulmonary fibrosis[J].Current Opinion in Pulmonary Medicine,2001,7(5):298-308.
5[5]Iyer SN,Hyde DM,Giri SN.Anti-inflammatory effect of pirfenidone in the bleomycin-hamster model of lung inflammation[J].Inflammation,2000,24(12):477-491.
6[7]Arslan SO,Zerin M,Vural H,et al.The effect of melatonin on bleomycin-induced pulmonary fibrosis in rats[J].J Pineal Res,2002,32(23):21-25.
7[8]Darryl CZ.The lipoxygenase pathway.A New therapeutic target for treatment of pulmonary fibrosis[J].Am J Respir Crit Care Med,2002,165(2):146-147.
8[9]Joseph AL,Luis AO.Antifibrotic therapy for the treatment of pulmonary fibrosis[J].Am J Med Sci,2001,322 (7):213-221.
